5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
about
Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communicationIncreased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice.Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?Genetic modifiers of atherosclerosis in miceDivergent effects of low-O(2) tension and iloprost on ATP release from erythrocytes of humans with type 2 diabetes: implications for O(2) supply to skeletal muscleCardiovascular effects of sulphonylureas: role of K(ATP) channels.Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study.Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study.Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.Type 2 diabetes mellitus in adolescence: lipid and cardiovascular risk factors.The prevalence of peripheral arterial disease in korean patients with type 2 diabetes mellitus attending a university hospital.Diabetic macrovascular disease and serum lipids: is there a connection?Vascular risk: diabetes.Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats.Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosisThe metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention.Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation.NOX enzymes and diabetic complications.Racial difference in Acylation Stimulating Protein (ASP) correlates to triglyceride in non-obese and obese African American and Caucasian women.Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community.Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area.The role of haematological factors in diabetic peripheral arterial disease: the Edinburgh artery study.Cardiovascular effects of oral hypoglycaemic drugs.Determinants of coronary vascular disease in patients with type II diabetes mellitus and their therapeutic implications.Lipids, thrombosis and cardiovascular disease in diabetes.Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.Glycogen synthase kinase-3 negatively regulates tissue factor expression in monocytes interacting with activated platelets.Cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients with peripheral artery disease.Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy.Sodium tungstate attenuate oxidative stress in brain tissue of streptozotocin-induced diabetic rats.Glucose regulates interleukin-8 production in aortic endothelial cells through activation of the p38 mitogen-activated protein kinase pathway in diabetes.Cholesterol rich apo B containing lipoproteins and smoking are independently associated with macrovascular disease in normotensive NIDDM patients.Plasma interleukin-6 is associated with coagulation in poorly controlled patients with Type 2 diabetes.Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction.Predictors for peripheral and carotid revascularization in a population-based cohort with type 2 diabetes.A novel complex of arginine-silicate improves micro- and macrovascular function and inhibits glomerular sclerosis in insulin-resistant JCR:LA-cp rats.Hypersensitivity of prediabetic JCR:LA-cp rats to fine airborne combustion particle-induced direct and noradrenergic-mediated vascular contraction.
P2860
Q24598135-0629CAF1-8522-4966-85EE-674322466F7EQ30310826-717EABB2-8B3C-47C0-97ED-C8D6221ED2F5Q33204826-5A17EAE8-1F03-4F27-9FDC-4FED38805B03Q34068407-ABA793B3-EA98-46AE-9EEC-312AC359812CQ34080318-A6D8C1CD-0FF4-48D2-BB74-C6ACB222EA61Q34092917-F76AB3FF-2AE2-457D-A809-B2BD4AC6EF6FQ34163342-970267AF-203A-4F43-8162-5A05AB2C84CBQ34262967-2AE584C3-F31E-4DC1-8221-517CA2798E3EQ34422821-EF1C7413-324A-49F2-B37D-7E425A0885C3Q34432623-B2DCA5A4-AA14-4992-B769-3DEAAC76057EQ35134259-72738264-301D-42D2-AFD9-AB061D081F13Q35564091-70708AFA-D36E-472B-8A8E-3A8FF17E6BDDQ35932318-B4AE93DE-C069-45F1-A09A-D77DD9CB3595Q36023075-4CA2F0F7-A9A4-498D-958A-6E49BDB05133Q36052731-E0DCBCBD-584A-4B92-BD48-6EC6FC5E3B51Q36124082-EEC8B97C-E6B4-48BB-A405-69551B7440F7Q36218262-FFA907D4-B587-4B99-9C3C-7071655C1EE5Q36401585-857D82CC-5A3A-465F-A266-EC89A3977B71Q36839933-1F0CDA84-BAEA-49E6-9209-7B405ED3E227Q37167303-613FC97F-C03C-47DF-976B-4CF358555050Q37184230-2D0D4562-CAD3-41B0-8136-AA191F090115Q37242527-254ACFDA-129C-4A5B-BE81-7ED77E076AD8Q39229644-5E2266CE-4117-4D31-BB5F-974754138D6BQ39404247-4816C63B-FFCA-48B7-B322-F11DA6945148Q40811005-BB647352-73A8-41D8-ACA1-EB8199B6F1D7Q41230943-9E63FC80-5836-4EF7-BDF7-5918137065F2Q41457652-92671C9D-A194-4A80-BC6A-5EFE07FD7965Q41486255-884A0BD9-B54A-4F56-B1C6-DFC60698AC85Q42506566-573A15CC-3A38-40BD-AEBC-E22F98867B44Q42731445-4C548CDE-885D-4C58-A375-608E293F5624Q42849411-704D1F7F-C388-4ABF-AF3B-E430A7335689Q43131789-9EF78872-F5DC-44A1-B732-AC23ACA0A56CQ43260357-FA5C52EB-C920-4322-AB00-A06BA4C44ABCQ43644800-38700856-D32F-4C75-B3A2-137E16E0CD02Q43801501-2B848453-B097-4564-9146-758095867D02Q44665361-4E68E485-B6DC-4691-AA18-E114C5CF9EF1Q46186192-61A86BCC-CEDD-40CF-A7C4-AD4C6D175567Q46570660-0DB3C21B-58E2-4AEE-AAEE-3CC796C3F0A3Q46577859-069CBCB8-2D99-47C6-B3EA-02B572E0E7B7Q46890214-1BD46F72-C609-44A7-B4E7-94ED9A5BD5F9
P2860
5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
5-year incidence of atheroscle ...... etic and nondiabetic subjects.
@en
5-year incidence of atheroscle ...... etic and nondiabetic subjects.
@nl
type
label
5-year incidence of atheroscle ...... etic and nondiabetic subjects.
@en
5-year incidence of atheroscle ...... etic and nondiabetic subjects.
@nl
prefLabel
5-year incidence of atheroscle ...... etic and nondiabetic subjects.
@en
5-year incidence of atheroscle ...... etic and nondiabetic subjects.
@nl
P2093
P921
P356
P1433
P1476
5-year incidence of atheroscle ...... etic and nondiabetic subjects.
@en
P2093
Niskanen LK
Siitonen O
Uusitupa MI
Voutilainen E
P356
10.1161/01.CIR.82.1.27
P407
P577
1990-07-01T00:00:00Z